|
negative regulation of apoptotic signaling pathway
|
GO_2001234 |
[Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic signaling pathway.] |
|
regulation of apoptosome assembly
|
GO_1905100 |
[Any process that modulates the frequency, rate or extent of apoptosome assembly.] |
|
positive regulation of apoptosome assembly
|
GO_1905102 |
[Any process that activates or increases the frequency, rate or extent of apoptosome assembly.] |
|
GO_0006160
|
GO_0006160 |
|
|
deoxyguanosine catabolic process
|
GO_0006161 |
[The chemical reactions and pathways resulting in the breakdown of deoxyguanosine, a nucleoside consisting of the base guanine and the sugar deoxyribose.] |
|
positive regulation of smooth muscle hypertrophy
|
GO_1905149 |
[Any process that activates or increases the frequency, rate or extent of smooth muscle hypertrophy.] |
|
regulation of smooth muscle hypertrophy
|
GO_1905147 |
[Any process that modulates the frequency, rate or extent of smooth muscle hypertrophy.] |
|
obsolete purine/pyrimidine nucleoside diphosphate reduction
|
GO_0006162 |
[OBSOLETE. (Was not defined before being made obsolete).] |
|
snRNA pseudouridine synthesis
|
GO_0031120 |
[The intramolecular conversion of uridine to pseudouridine in an snRNA molecule.] |
|
snRNA modification
|
GO_0040031 |
[The covalent alteration of one or more nucleotides within snRNA, resulting in a change in the properties of the snRNA.] |
|
negative regulation of smooth muscle hypertrophy
|
GO_1905148 |
[Any process that stops, prevents or reduces the frequency, rate or extent of smooth muscle hypertrophy.] |
|
obsolete nucleoside diphosphate phosphorylation
|
GO_0006165 |
[OBSOLETE. The process of introducing a phosphate group into a nucleoside diphosphate to produce a nucleoside triphosphate.] |
|
equatorial microtubule organization
|
GO_0031121 |
[A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of structures formed of microtubules and associated proteins at the midpoint of a cell.] |
|
purine ribonucleoside salvage
|
GO_0006166 |
[Any process which produces a purine nucleoside from derivatives of it, without de novo synthesis.] |
|
purine-containing compound salvage
|
GO_0043101 |
[Any process that generates a purine-containing compound, any nucleobase, nucleoside, nucleotide or nucleic acid that contains a purine base, from derivatives of them without de novo synthesis.] |
|
nucleoside salvage
|
GO_0043174 |
[Any process which produces a nucleotide, a nucleobase linked to either beta-D-ribofuranose (ribonucleoside) or 2-deoxy-beta-D-ribofuranose (a deoxyribonucleotide), from derivatives of it without de novo synthesis.] |
|
AMP metabolic process
|
GO_0046033 |
[The chemical reactions and pathways involving AMP, adenosine monophosphate.] |
|
adenine salvage
|
GO_0006168 |
[Any process that generates adenine, 6-aminopurine, from derivatives of it without de novo synthesis.] |
|
purine nucleobase salvage
|
GO_0043096 |
[Any process that generates purine nucleobases, one of the two classes of nitrogen-containing ring compounds found in DNA and RNA, from derivatives of them without de novo synthesis.] |
|
adenine biosynthetic process
|
GO_0046084 |
[The chemical reactions and pathways resulting in the formation of adenine, 6-aminopurine, one of the five main bases found in nucleic acids and a component of numerous important derivatives of its corresponding ribonucleoside, adenosine.] |